Cite
HARVARD Citation
Motzer, R. et al. (2022). Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Journal for immunotherapy of cancer. 10 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Motzer, R. et al. (2022). Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Journal for immunotherapy of cancer. 10 (3), p. . [Online].